Semiconductor and life sciences technology company developing next-generation biochip platforms based on thin-film transistor (TFT) semiconductor technology. With its UK research and business development centre located in Cambridge, the company combines expertise in semiconductor engineering, synthetic biology, and biotechnology to create high-throughput tools for DNA synthesis, microarray applications, molecular diagnostics, and biological sensing. LinkZill’s proprietary TFT biochip platform enables precise control of biological reactions at scale, helping researchers and industry partners accelerate innovation in genomics, synthetic biology, and life science research. Serving customers across academia and industry worldwide, the company is advancing the convergence of semiconductor technology and biotechnology to support the next generation of scientific discovery and healthcare innovation.